Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$7.4M-158%-$2.86M+14.2%-$3.34M-14.1%-$2.93M+11.2%-$3.29M+48.9%
$4.39M+5.9%$4.15M-9.9%$4.6M-1.7%$4.68M-2.2%$4.78M-2.4%
$440.95K+8.0%$408.32K+31.3%$310.97K+1.6%$306.08K+2.9%$297.35K-1.5%
$1.42M-71.2%$4.93M
$50.27K-48.6%$97.9K-2.3%$100.19K+9.2%$91.78K+26.6%$72.47K+9.0%
-$3.83M+23.4%-$4.99M
$78.61K-70.2%$263.48K-27.2%$361.86K-19.6%$450.24K-22.0%$577.31K-0.3%
$38.33M+6.5%
-$1.98M+70.6%-$6.75M
$1.37M-71.6%$4.83M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Cumberland Pharmaceuticals generate?
Cumberland Pharmaceuticals (CPIX) generated $1.4M in operating cash flow over the trailing twelve months.
What is Cumberland Pharmaceuticals's free cash flow?
After $50.3K of capital expenditures, Cumberland Pharmaceuticals's free cash flow was $1.4M over the trailing twelve months, down 23.9% year over year.
Where does Cumberland Pharmaceuticals's cash flow data come from?
Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.